Lonza Vacaville
total capacity of 332,000L
CAPACITY · WHAT THE NUMBER MEANS
Disclosed vessel sizes and total site litres orient an early screen, but they do not establish working volume, site-level assignment, current operations, or open campaign slots.
total capacity of 332,000L
6,000L and 20,000L stainless steel bioreactors
8 × 20,000 L mammalian reactors opened
60,000 L
provides 60 kL capacity
36,000L (6 x 6,000L) single-use capacity; up to 12,000L per batch
Madison: 100 to 4,000-liter single-use (three 2x2,000L, 1,000L, 500L); Bloomington: two 2,500L stainless steel + 1,000L single-use
9 × 2,000 L single-use; 3,000 L stainless steel
Capacity figure unknown in reviewed sources.
Capacity figure unknown in reviewed sources.
Capacity figure unknown in reviewed sources.
Vendor figures retain their own wording and units; they are not directly comparable and do not show capacity available to book.
For a program-specific screen, request vessel-level working volumes, stainless vs single-use train configuration, changeover constraints, and a current availability window.
← Return to the site comparison
Neither figure tells you when your manufacturing campaign can start.
AGC lists nine 2,000 L single-use reactors and 3,000 L stainless-steel reactors at Seattle. It describes running multiple 2,000 L vessels together or in sequence.
These are equipment and scale-out statements, not one vessel’s working volume or capacity available to book. The number of 3,000 L reactors is not stated. Source & date
Fujifilm reports eight 20,000 L mammalian reactors already opened at Holly Springs. Another eight are under expansion, targeted for late FY2027.
The extra reactors are a target, not installed capacity in this comparison. The announced drug-product line is targeted for early 2027. No available slots are published. Source & date